Cypress Wealth Services LLC boosted its position in shares of Merck & Co., Inc. (NYSE:MRK) by 2.9% during the first quarter, according to the company in its most recent filing with the Securities and
Capital Investment Advisory Services LLC increased its holdings in shares of Merck & Co., Inc. (NYSE:MRK) by 58.7% during the 1st quarter, according to its most recent Form 13F filing with the Securit
Bruderman Asset Management LLC boosted its holdings in Merck & Co., Inc. (NYSE:MRK) by 1.3% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 110
Citizens National Bank Trust Department bought a new position in shares of Merck & Co., Inc. (NYSE:MRK) in the 1st quarter, Holdings Channel reports. The fund bought 42,928 shares of the company’s s
Birmingham Capital Management Co. Inc. AL reduced its stake in shares of Merck & Co., Inc. (NYSE:MRK) by 2.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchan
Phibro Animal Health (NASDAQ:PAHC) was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Thursday, BidAskClub reports. A number of other research
American Investment Services Inc. increased its stake in shares of Merck & Co., Inc. (NYSE:MRK) by 6.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Com
DZ Bank reaffirmed their buy rating on shares of Bayer (FRA:BAYN) in a research report sent to investors on Monday morning, Borsen Zeitung reports. A number of other analysts have also weighed in on B
Phibro Animal Health (NASDAQ:PAHC) will announce its earnings results after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of $0.35 per share for the quarter.
Clark Estates Inc. NY acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor
Q1 2020 Merck & Co Inc Earnings Call

Merck & Company (MRK) Receives a Buy from Barclays

12:15pm, Wednesday, 29'th Apr 2020
Barclays analyst Carter Gould maintained a Buy rating on Merck & Company (MRK) yesterday and set a price target of $90.00. The company's shares closed

Merck & Company (MRK) Receives a Buy from Barclays

12:15pm, Wednesday, 29'th Apr 2020
Barclays analyst Carter Gould maintained a Buy rating on Merck & Company (MRK – Research Report) yesterday and set a
Bridgeworth LLC increased its position in Merck & Co., Inc. (NYSE:MRK) by 5.3% during the first quarter, Holdings Channel.com reports. The institutional investor owned 2,689 shares of the company’s
Blue Fin Capital Inc. decreased its stake in Merck & Co., Inc. (NYSE:MRK) by 1.0% in the 1st quarter, Holdings Channel.com reports. The fund owned 28,843 shares of the company’s stock after selling
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE